Ipsen : adds another program into its pre-clinical R&D Oncol

Ipsen adds another program into its pre-clinical R&D Oncology pipeline through an exclusive worldwide collaboration with Accent Therapeutics, targeting the RNA modifying protein, METTL3

...

Related Keywords

France , United States , American , Oumin Shi , P Ann Boriack Sjodin , Zacharya Gurard Levin , Scott Ribich , Ipsen Euronext , Roberta Copeland , Xiaoquin Lu , Shakti Narayan , Jeffreyl Hirsch , Christelle Huguet , Quanxiang Zeng , Benjamind Wheeler , Michaeld Scholle , Yong Li , Shanem Buker , Wei Wang , Qi Wang , Early Development , American Cancer Society , Head Of Research , Accent Therapeutics , Senior Vice President , External Innovation , Chief Executive Officer , Acute Myeloid , Aprilw Case , Mass Spectrometric Assay , Markets ,